Nemaura Medical to Exhibit and Provide Live Product Demonstrations of Its Non-invasive Glucose Sensor at the 83rd Scientific Sessions of the American Diabetes Association June 23-26, 2023
| NMRDDelisted Stock | USD 0.93 0.01 1.06% |
About 61% of Nemaura Medical's investor base is looking to short. The analysis of overall sentiment of trading Nemaura Medical pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Nemaura Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Nemaura Medical stock news signals to limit their universe of possible portfolio assets.
Nemaura Medical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nemaura daily returns and investor perception about the current price of Nemaura Medical as well as its diversification or hedging effects on your existing portfolios.
Nemaura |
LOUGHBOROUGH, June 15, 2023 Nemaura Medical, Inc. , a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized diabetes management and metabolic health programs, today announces it will exhibit and provide product demonstrations of its non-invasive daily-wear glucose sensor platform at the 83rd Scientific Sessions of the American Diabetes Association. The meeting w
Read at finance.yahoo.com
 |
Nemaura Medical Fundamental Analysis
We analyze Nemaura Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nemaura Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nemaura Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Nemaura Medical is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Nemaura Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nemaura Medical pink sheet to make a market-neutral strategy. Peer analysis of Nemaura Medical could also be used in its relative valuation, which is a method of valuing Nemaura Medical by comparing valuation metrics with similar companies.
Peers
Nemaura Medical Related Equities
| MOVE | Movano | 6.20 | ||||
| NPCE | Neuropace | 3.50 | ||||
| CVRX | CVRx | 3.33 | ||||
| AORT | Artivion | 1.82 | ||||
| OFIX | Orthofix Medical | 1.40 | ||||
| ELMD | Electromed | 0.91 | ||||
| SRDX | SurModics | 0.40 | ||||
| BJDX | Bluejay Diagnostics | 1.54 | ||||
| NVNO | EnVVeno Medical | 1.58 | ||||
| MODD | Modular Medical | 2.80 | ||||
| SSKN | STRATA Skin | 5.25 | ||||
| NXL | Nexalin Technology | 14.05 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |